Manufacture Advanced Medicine, Trends & Forecasts

Oligonucleotide therapeutics: manufacturing for research and beyond

10/19/2023

sponsored by Cytiva

It’s time for oligonucleotide therapeutics to step into the light. With an increase in therapies in preclinical and clinical stages, many therapeutic developers find that they need to scale up quickly to meet demand.

Considering manufacturability and scale-up during small-scale method development will help deliver process efficiency and scalability, ensuring smooth technology transfer and saving time and materials. In this presentation, we’ll discuss strategies to future-proof your manufacturing for vaccines, therapeutics, and more.

An overview of the current clinical landscape for oligo therapeutics
Key considerations for starting in-house oligonucleotide synthesis
Considerations for clinical scale-up

View On-Demand

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.